Abstract | BACKGROUND: OBJECTIVE: To analyze the prevalence of the +936 C/T VEGF gene polymorphism among patients with DM2 with and without peripheral neuropathy. STUDY DESIGN AND METHODOLOGY: 218 unrelated DM2 patients, 90 with and 128 without peripheral neuropathy were genotyped for the +936 C/T VEGF gene polymorphism using PCR amplification followed by restriction length polymorphism analysis. RESULTS: The CC homozygous VEGF+936 C/T (rs3025039) was the predominant genotype in DM2 patients with peripheral neuropathy, whereas the predominant genotype in patients without neuropathy was the heterozygous C/T. No statistical association was found between genotype distribution and the presence of neuropathy (p = 0.063). The distribution of the genotypes according to the dominant (CC vs. CT + TT) and recessive (TT vs. CT + CC) models showed that the homozygous CC and TT genotypes, respectively, are not risk factors for neuropathy. The CT genotype conferred a protective effect as seen in the over-dominant model (CT vs. CC + TT) (OR = 0.52; 95% CI = 0.300-0.90; p = 0.019). CONCLUSION: We conclude that the VEGF+936 C/T (rs3025039) gene polymorphisms are related to peripheral neuropathy in Mexican DM2 patients, with the heterozygous genotype potentially conferring a protective effect.
|
Authors | Veronica Kimberly Arredondo-García, Ana Cecilia Cepeda-Nieto, Tania Batallar-Gómez, Mauricio Salinas-Santander, Alejandro Zugasti-Cruz, Luis Ramírez-Calvillo, Karina Maldonado-Sánchez, Jesus Morlett-Chávez, Hector Barajas-Martínez |
Journal | Archives of medical research
(Arch Med Res)
Vol. 50
Issue 4
Pg. 181-186
(05 2019)
ISSN: 1873-5487 [Electronic] United States |
PMID | 31499478
(Publication Type: Journal Article)
|
Copyright | Copyright © 2019 IMSS. Published by Elsevier Inc. All rights reserved. |
Chemical References |
- Vascular Endothelial Growth Factor A
|
Topics |
- Adult
- Aged
- Diabetes Mellitus, Type 2
(genetics)
- Diabetic Neuropathies
(genetics)
- Female
- Genetic Predisposition to Disease
- Humans
- Male
- Middle Aged
- Risk Factors
- Vascular Endothelial Growth Factor A
(genetics, metabolism)
|